Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.13T | 1.43T | 1.36T | 1.16T | 1.19T | 1.05T |
Gross Profit | |||||
2.13T | 2.36T | 1.36T | 1.16T | 1.19T | 1.05T |
EBIT | |||||
450.31B | 1.07T | 344.63B | 257.84B | 202.20B | 110.50B |
EBITDA | |||||
-7.67B | 623.70B | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income Common Stockholders | |||||
453.16B | 442.56B | 340.37B | 251.10B | 183.84B | 95.66B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
495.94B | 3.55T | 764.89B | 807.23B | 1.08T | 1.03T |
Total Assets | |||||
7.48T | 23.64T | 19.58T | 17.53T | 15.74T | 13.77T |
Total Debt | |||||
1.84T | 2.01T | 1.89T | 1.62T | 1.44T | 2.14T |
Net Debt | |||||
1.35T | 108.69B | 526.05B | -215.23B | -36.71B | 859.99B |
Total Liabilities | |||||
6.69T | 20.94T | 17.37T | 15.65T | 14.07T | 12.48T |
Stockholders Equity | |||||
764.30B | 2.56T | 2.14T | 1.82T | 1.58T | 1.23T |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.54T | -62.39B | 562.51B | 1.36T | 776.91B |
Operating Cash Flow | |||||
0.00 | 1.57T | -37.71B | 581.11B | 1.38T | 795.65B |
Investing Cash Flow | |||||
0.00 | -1.46T | -680.05B | -393.21B | -629.87B | -423.08B |
Financing Cash Flow | |||||
0.00 | 137.65B | 247.91B | 174.51B | -546.67B | 29.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $117.36B | 19.88 | 18.52% | 0.61% | 24.97% | 13.74% | |
76 Outperform | $56.84B | 8.80 | 20.84% | 6.13% | -7.01% | 15.18% | |
76 Outperform | $55.99B | 11.70 | 9.95% | 3.87% | 36.29% | -19.79% | |
73 Outperform | $170.88B | 21.99 | 14.96% | 0.82% | 37.85% | 0.54% | |
70 Outperform | $22.11B | 7.36 | 10.44% | 1.34% | -8.55% | 13.58% | |
70 Outperform | $17.47B | 14.14 | 11.61% | 4.66% | -3.94% | 31.52% | |
62 Neutral | $11.85B | 9.13 | 8.11% | 79.54% | 12.80% | -5.24% |